GOLD科学委员会关于支气管舒张前后肺功能用于慢阻肺诊断的建议
GOLD科学委员会综述比较了支气管舒张前与舒张后肺功能对慢阻肺诊断的影响。队列研究显示多数情况诊断一致,但舒张后慢阻肺患病率可低36%,存在容量反应者与流量反应者两类不一致情形。GOLD 2025推荐舒张前肺功能用于排除慢阻肺,舒张后用于确诊,以减少临床工作量并避免过度诊断。
要点
- GOLD 2025推荐舒张前肺功能排除慢阻肺,舒张后肺功能确诊。
- 舒张后肺功能可避免漏诊容量反应者并限制慢阻肺过度诊断。
- 舒张后结果接近阈值时应重复检查以确保诊断正确。
核心结论
- GOLD 2025推荐使用支气管舒张前肺功能排除慢阻肺,使用舒张后肺功能确诊慢阻肺。
研究设计与样本
- GOLD科学委员会综述,综合队列研究证据评估舒张前与舒张后肺功能用于慢阻肺诊断。
主要发现
- 队列研究显示舒张前与舒张后肺功能在多数情况下给出 concordant 诊断结果,但舒张后慢阻肺患病率可低36%。
- 容量反应者舒张前 FEV1/FVC≥0.7,舒张后因 FVC 改善大于 FEV1 使比值降至<0.7。
- 流量反应者舒张前 FEV1/FVC<0.7,舒张后因 FEV1 改善大于 FVC 使比值升至≥0.7,且随访中更易出现舒张后阻塞。
关键数值与推荐
- 慢阻肺确诊需支气管舒张后 FEV1/FVC<0.7。
- GOLD 2025推荐舒张前肺功能用于排除慢阻肺,舒张后用于确诊。
- 舒张后结果接近阈值时应重复检查以确保诊断正确。
临床怎么用
- 临床可先用舒张前肺功能排除慢阻肺,再以舒张后肺功能确诊,以减少工作量。
- 对流量反应者应进行纵向监测,因其后续出现舒张后阻塞的可能性增加。
- 舒张后结果接近诊断阈值时需重复肺功能检查以避免误诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) report states that the diagnosis of COPD should be considered in individuals with chronic respiratory symptoms and/or exposure to risk factors. Forced spirometry demonstrating airflow obstruction after bronchodilation is required to confirm the diagnosis using a threshold of forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) ratio <0.7. This GOLD Science Committee review weighs the evidence for using pre- or post-bronchodilator (BD) spirometry to diagnose COPD. Cohort studies have shown that pre- and post-BD spirometry give concordant diagnostic results in most cases, although the prevalence of COPD is up to 36% lower with post-BD values. Discordant results may occur in "volume" or "flow" responders. Volume responders have reduced FVC due to gas trapping causing FEV1/FVC ≥0.7 pre-BD, but a volume response occurs post-BD with a greater improvement in FVC relative to FEV1 decreasing the ratio to <0.7. Flow responders show a greater FEV1 improvement relative to FVC which may increase FEV1/FVC from <0.7 pre-BD to ≥0.7 post-BD; these individuals have an increased likelihood of developing post-BD obstruction during follow-up and require monitoring longitudinally. GOLD 2025 recommends using pre-BD spirometry to rule out COPD and post-BD measurements to confirm the diagnosis. This will reduce clinical workload. Post-BD results close to the threshold should be repeated to ensure a correct diagnosis is made. Post-BD measurements ensure that volume responders are not overlooked and limit COPD overdiagnosis.
引用
- Singh, Stockley, Anzueto, et al. GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry for the diagnosis of COPD. Eur Respir J. 2025. PMID: 39638416. doi:10.1183/13993003.01603-2024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。